Astragaloside IV inhibits nasopharyngeal carcinoma progression by inhibiting SATB2/Wnt/PD-L1 pathway and enhancing the killing activity of T cells.

Zeng Y, Huang J, Duan T, Wang X

Open source

DOI
10.4081/ejh.2026.4540
Published
2026 Apr 20
Container
European journal of histochemistry : EJH
Publisher
Not recorded
Open access
yes

Credibility signals

limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.4081/ejh.2026.4540,
  title = {Astragaloside IV inhibits nasopharyngeal carcinoma progression by inhibiting SATB2/Wnt/PD-L1 pathway and enhancing the killing activity of T cells.},
  author = {Zeng Y and Huang J and Duan T and Wang X},
  year = {2026},
  journal = {European journal of histochemistry : EJH},
  doi = {10.4081/ejh.2026.4540},
  url = {https://doi.org/10.4081/ejh.2026.4540}
}

RIS

TY  - JOUR
TI  - Astragaloside IV inhibits nasopharyngeal carcinoma progression by inhibiting SATB2/Wnt/PD-L1 pathway and enhancing the killing activity of T cells.
AU  - Zeng Y
AU  - Huang J
AU  - Duan T
AU  - Wang X
PY  - 2026
JO  - European journal of histochemistry : EJH
DO  - 10.4081/ejh.2026.4540
UR  - https://doi.org/10.4081/ejh.2026.4540
ER  - 

APA

Y, Z., J, H., T, D., & X, W. (2026). Astragaloside IV inhibits nasopharyngeal carcinoma progression by inhibiting SATB2/Wnt/PD-L1 pathway and enhancing the killing activity of T cells.. European journal of histochemistry : EJH. https://doi.org/10.4081/ejh.2026.4540

Source records